Boston Scientific, Inc. BSX recently gained the FDA’s approval for the FARAPULSE Pulsed Field Ablation (“PFA”) system, which is indicated for the isolation of pulmonary veins in the treatment of ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced a series of major milestones ...

Abbott has reported new data from its prospective, non-randomised Volt CE Mark Study, indicating that individuals treated with pulsed field ablation (PFA) therapy using the Volt PFA System for atrial ...

The MarketWatch News Department was not involved in the creation of this content. SHENZHEN, China, Aug. 4, 2025 /CNW/ -- Pulsecare Medical, a pioneer in cardiovascular intervention technologies, ...

The MarketWatch News Department was not involved in the creation of this content. SHENZHEN, China, Aug. 4, 2025 /PRNewswire/ -- Pulsecare Medical, a pioneer in cardiovascular intervention technologies ...

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...

The spotlight is now on Medtronic, as the medtech giant is the first to win FDA approval for a pulsed field ablation system (PFA). The Dublin-based company secures the nod before Boston Scientific ...